Home/Filings/4/0001615219-19-000031
4//SEC Filing

McVicar William K. 4

Accession 0001615219-19-000031

CIK 0001615219other

Filed

Sep 11, 8:00 PM ET

Accepted

Sep 12, 9:58 PM ET

Size

9.9 KB

Accession

0001615219-19-000031

Insider Transaction Report

Form 4
Period: 2019-09-10
McVicar William K.
President, R&D
Transactions
  • Award

    Stock Option (right to buy)

    2019-09-10+3,0003,000 total
    Exercise: $8.00From: 2019-12-31Exp: 2029-09-10Common Stock (3,000 underlying)
Footnotes (1)
  • [F1]On July 19, 2019, the Issuer effected a 1-for-25 reverse stock split of its then outstanding common stock, resulting in the reporting person's ownership of 34,385 options.

Issuer

Salarius Pharmaceuticals, Inc.

CIK 0001615219

Entity typeother

Related Parties

1
  • filerCIK 0001634368

Filing Metadata

Form type
4
Filed
Sep 11, 8:00 PM ET
Accepted
Sep 12, 9:58 PM ET
Size
9.9 KB